# Immunonutrition for Diabetic Foot Ulcers

> **NCT05281562** · PHASE2,PHASE3 · TERMINATED · sponsor: **Prisma Health-Midlands** · enrollment: 1 (actual)

## Conditions studied

- Diabetes Mellitus
- Diabetic Peripheral Neuropathy
- Diabetic Foot Ulcer

## Interventions

- **DRUG:** Lovaza
- **DRUG:** L-Arginine Powder
- **DRUG:** Vitamin C

## Key facts

- **NCT ID:** NCT05281562
- **Lead sponsor:** Prisma Health-Midlands
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-08
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Not enough patients meeting eligibility criteria to complete the study. It took months from study initiation to enroll 1 participant in February 2023. Once it was clear it was not possible to enroll another participant, the study was terminated.
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05281562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05281562, "Immunonutrition for Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05281562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*